Therapeutic Nanoparticles for Drug Delivery in Cancer
Top Cited Papers
- 1 March 2008
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (5), 1310-1316
- https://doi.org/10.1158/1078-0432.ccr-07-1441
Abstract
Cancer nanotherapeutics are rapidly progressing and are being implemented to solve several limitations of conventional drug delivery systems such as nonspecific biodistribution and targeting, lack of water solubility, poor oral bioavailability, and low therapeutic indices. To improve the biodistribution of cancer drugs, nanoparticles have been designed for optimal size and surface characteristics to increase their circulation time in the bloodstream. They are also able to carry their loaded active drugs to cancer cells by selectively using the unique pathophysiology of tumors, such as their enhanced permeability and retention effect and the tumor microenvironment. In addition to this passive targeting mechanism, active targeting strategies using ligands or antibodies directed against selected tumor targets amplify the specificity of these therapeutic nanoparticles. Drug resistance, another obstacle that impedes the efficacy of both molecularly targeted and conventional chemotherapeutic agents, might also be overcome, or at least reduced, using nanoparticles. Nanoparticles have the ability to accumulate in cells without being recognized by P-glycoprotein, one of the main mediators of multidrug resistance, resulting in the increased intracellular concentration of drugs. Multifunctional and multiplex nanoparticles are now being actively investigated and are on the horizon as the next generation of nanoparticles, facilitating personalized and tailored cancer treatment.Keywords
This publication has 58 references indexed in Scilit:
- Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovaryExpert Opinion on Pharmacotherapy, 2006
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2006
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Nanocarriers: Promising Vehicle for Bioactive DrugsBiological & Pharmaceutical Bulletin, 2006
- Applications of carbon nanotubes in drug deliveryCurrent Opinion in Chemical Biology, 2005
- Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast CancerJournal of Clinical Oncology, 2005
- Resistance to epidermal growth factor receptor-targeted therapyDrug Resistance Updates, 2005
- Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architectureChemical Communications, 2004
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- PegylationClinical Pharmacokinetics, 2001